×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
Yahoo Finance
Enlivex Therapeutics ENLV is a clinical-stage pharmaceutical company focused on developing its lead pipeline candidate, Allocetra,...
1 month ago
Enlivex defends sepsis data that sank stock, shifting focus from mortality to subgroup analysis
Fierce Biotech
Enlivex Therapeutics had a message Friday for investors who halved its share price: You're misreading our data.
1 month ago
Enlivex’s Stock Plummets 50% on Phase II Sepsis Results for Cell Therapy
BioSpace
Investors were disappointed in data from a mid-stage study of Enlivex Therapeutics' Allocetra cell therapy for the treatment of sepsis.
1 month ago
Enlivex reports positive data from Phase II sepsis treatment trial
Clinical Trials Arena
Enlivex Therapeutics has reported positive topline data from its Phase II clinical trial of Allocetra cell therapy in treating sepsis.
1 month ago
We Think Enlivex Therapeutics (NASDAQ:ENLV) Needs To Drive Business Growth Carefully
Simply Wall Street
Since it has a market capitalisation of US$80m, Enlivex Therapeutics' US$24m in cash burn equates to about 30% of its market value. That's...
1 month ago
Enlivex Therapeutics: Promising Trial Results for Allocetra - TipRanks.com
Tipranks
Enlivex Therapeutics (ENLV) has released an update. Enlivex Therapeutics, a clinical-stage immunotherapy company, has reported promising...
2 weeks ago
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled ...
GlobeNewswire
Nes-Ziona, Israel, April 16, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage...
1 month ago
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
Yahoo Finance
Enrollment completed in placebo-controlled, randomized, dose-finding, multi-country, multi-center Phase II sepsis studyTopline Data Expected...
4 months ago
Enlivex stock plunges 50% on mixed results from sepsis study (NASDAQ:ENLV)
Seeking Alpha
Shares of Enlivex Therapeutics (NASDAQ:ENLV) plunged 50% in late morning trading Thursday after the company reported bias issues in a Phase...
1 month ago
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial ...
GlobeNewswire
Nes-Ziona, Israel, April 11, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage...
1 month ago